New approach for cervical cancer vaccines based on microsphere-encapsulated peptides

As­cendis Phar­ma’s Yorvipath was ap­proved in Eu­rope on Mon­day, days af­ter the com­pa­ny re­filed its ap­pli­ca­tion for the hy­poparathy­roidism hope­ful in the US. Yorvipath, al­so

At the American Society of Clinical Oncology annual meeting, several important abstracts on endometrial cancer were presented, introducing some novel therapies that physicians are hoping